Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2010 / Article

Commentary | Open Access

Volume 7 |Article ID 791640 | https://doi.org/10.1093/ecam/nen051

Elizabeth H. Logue, "Geffen Faculty Highlight Concerns Linking CAIM and Conventional Researchers at UCLA Symposium", Evidence-Based Complementary and Alternative Medicine, vol. 7, Article ID 791640, 4 pages, 2010. https://doi.org/10.1093/ecam/nen051

Geffen Faculty Highlight Concerns Linking CAIM and Conventional Researchers at UCLA Symposium

Received12 Jun 2008
Accepted20 Jun 2008

Abstract

David Geffen School of Medicine faculty, representing a wide range of disciplines, engaged speakers nationally known for their expertise on complementary, alternative and integrative medicine (CAIM) and its investigation at a January, 2008 symposium on the campus of the University of California, Los Angeles. The forum was created to educate the UCLA Institutional Review Board (IRB), and lively participation by School of Medicine faculty helped bring IRB members up to speed on controversies surrounding CAIM research. The symposium demonstrated that academics who are neither proponents nor detractors of CAIM can facilitate cross talk between opposing camps, elucidating questions important to its evaluation by those charged with protecting research subjects. It also brought attention to the universality of quandaries facing CAIM investigators and to the ingenuity with which they have addressed many of them.

Copyright © 2010 Elizabeth H. Logue. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views509
Downloads435
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.